T he uptake and metabolism of nutrients is central to life, as it provides matter for the generation of energy and biomass. Many nutrients are reduced organic compounds, which can be oxidized to drive the formation of ATP from ADP and inorganic phosphate. During glycolysis, glucose is catabolized to pyruvate with concomitant ATP production. Carbons derived from pyruvate, amino acids and fatty acids can feed into the tricarboxylic acid (TCA) cycle for complete oxidation to CO 2 , which yields large quantities of ATP through oxidative phosphorylation 1 . Continuous re-generation of ATP allows cells to counteract their entropic decay, for instance by maintaining quality control of macromolecules and powering ion pumps that create electrochemical gradients. While the metabolism of quiescent cells is optimized for high ATP yield, a cell's metabolic needs alter greatly when the cell commits to growth and proliferation. Now, all components for doubling cellular mass must be acquired directly from extracellular sources or synthesized endogenously. To fulfil the metabolic demands of biomass formation, proliferating cells increase their uptake of nutrients and, rather than oxidizing them to CO 2 , reprogram glycolysis and the TCA cycle into biosynthetic hubs to generate building blocks for macromolecular synthesis 2 . Unicellular organisms and multicellular plants tend to have loose nutritional requirements and can produce energy and macromolecular precursors from many different organic substrates or even simple sources of reduced carbon and nitrogen. By contrast, mammalian cells use only a few abundant nutrients such as glucose, glutamine and fatty acids for the bulk of ATP production and non-essential metabolite synthesis (Fig. 1a) . However, mammalian cells lack the biosynthetic capacity to produce the diversity of metabolites required for cellular functions and must acquire various essential nutrients from extracellular sources 3 . For example, mammalian cells cannot synthesize de novo 10 essential proteinogenic amino acids that together make up almost a quarter of cell dry mass 4 ( Fig. 1b) . At least two fatty acids are essential: α -linolenic acid and linoleic acid, which serve as precursors for membrane and signalling lipids. Mammalian cells also require low quantities of vitamins and various inorganic ions. The complex metabolic requirements of cell growth are reflected in the composition of plasma and interstitial fluids, which contain a wide range of low-molecular-mass nutrients and macromolecules 5 . To obtain these diverse nutrients, cells have evolved several import pathways, including cell surface nutrient transporters, receptor-mediated endocytosis and macropinocytosis of bulk solutes.
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Because cancer is in part a disease of dysregulated growth, transformed cells have increased demands for nutrients such as glucose and glutamine to support macromolecular synthesis 2, 6 . However, solid tumour growth frequently creates regional nutrient deficiencies by outstripping the vascular supply. It is becoming clear that malignant cells can survive and grow in vascularly compromised environments by exploiting the full array of nutrients available extracellularly, including low-molecular-mass nutrients as well as macromolecules and cellular debris. The capacity to enhance anabolic metabolism has emerged as a core feature of many oncogene and tumour suppressor pathways that is fundamental to their carcinogenic action 7, 8 . At the same time, research into the metabolism of transformed cells has contributed substantially to the understanding of how cells regulate nutrient usage during physiological processes such as growth and adaptation to stress. Here, we review strategies by which mammalian cells acquire and use the diverse low-molecular-mass nutrients and macromolecules that are present in the extracellular space. We highlight cellular pathways that function in nutrient uptake and discuss their regulation by signalling pathways and dysregulation during cancer development.
Growth factors control metazoan nutrient uptake
Unicellular organisms acquire nutrients as they become available in the environment and adjust anabolic pathway activities and macromolecular synthesis rates accordingly. For such organisms, nutrients not only supply biosynthetic substrates, but also serve as principal signals to engage in proliferation (Fig. 2a) . The discovery that growth factors initiate cell cycle entry in metazoan organisms led to the assumption that cellular metabolism could be disregarded as a regulator of animal cell proliferation. Rather, it was assumed that growth-factor-induced proliferation raised a cell's bioenergetic and biosynthetic demands, with nutrient uptake being increased as a passive consequence. However, it has become clear over the last 15 years that growth factors act as cell-extrinsic regulators of nutrient acquisition and usage in metazoan cells 2, 7 (Fig. 2b) . Downstream of growth-factor-activated receptor tyrosine kinases, the phosphoinositide 3-kinase (PI3K) and Ras signalling pathways are central regulators of cellular nutrient acquisition. PI3K and Ras directly promote nutrient uptake to supply growing cells with sufficient resources for biomass formation, and concomitantly increase the expression or activity of biosynthetic enzymes to allocate nutrients for anabolism.
Because metazoan cells are commonly surrounded by nourishing body fluids, placing nutrient uptake under cell-extrinsic control constitutes a metabolic adaptation of multicellular animals to prevent excessive consumption of the body's resources and to suppress aberrant proliferation Cell-extrinsic regulation of nutrient uptake constitutes a fundamental barrier for cellular transformation: to employ the unchecked anabolic metabolism characteristic for cancer, a cell must acquire mutations that permit independent control of nutrient access (Fig. 2c) . The oncogenic potential of signalling pathways such as the PI3K and Ras pathways lies in part in their ability to increase cellular autonomy for both cell cycle entry and nutrient acquisition, which conspire to drive tumour cell proliferation.
Cellular nutrient sensors adjust nutrient uptake
Like unicellular eukaryotes, metazoan cells use a variety of nutrientresponsive signalling networks to regulate nutrient acquisition and coordinate the use of metabolic resources. By surveying the abundance of energy and key metabolites, intracellular nutrient sensors play an important role in metabolic homeostasis and cell survival. For instance, the sterol response element binding protein (SREBP) pathway surveys cholesterol levels in endoplasmic reticulum membranes. When cellular cholesterol levels decrease, SREBP undergoes proteolytic cleavage and is released from the membrane. Subsequently, SREBP translocates to the nucleus and induces the expression of lipoprotein receptors to increase cholesterol acquisition from extracellular sources and expression of lipogenic enzymes to enhance de novo biosynthesis 9 . In this manner, SREBP acts as an internal sensor that helps to maintain the balance of phospholipids and cholesterol in cellular membranes.
Nutrient sensors can also adjust the use of nutrients for energy production and macromolecular synthesis in response to cellular metabolite levels 10 . The kinase mechanistic target of rapamycin complex b, The cells of metazoan organisms have lost the ability to regulate nutrient acquisition cell-autonomously; rather, they are instructed by growth factor signalling pathways to engage in nutrient uptake, thereby ensuring that nutrient supply matches the metabolic demands of cell growth. c, Components of growth factor signalling pathways are frequently mutated in cancer. These oncogenes cause cellular transformation in part by granting a cell autonomy over nutrient uptake and by increasing the availability of precursors for macromolecular synthesis.
1 (mTORC1) is a central coordinator of amino acid availability and cell growth 11, 12 . Activation of mTORC1 requires abundant intracellular amino acids. Once active, mTORC1 enhances the consumption of amino acids in protein translation and also stimulates other anabolic processes, including lipid and nucleotide synthesis (Fig. 3) . Concomitantly, mTORC1 suppresses macromolecular catabolism by blocking autophagy, which targets intracellular constituents for degradation in the lysosome. Many functions of mTORC1 are antagonized by AMP-activated protein kinase (AMPK), a sensor of cellular energy levels that becomes active when AMP levels rise 13 . AMPK initiates autophagy and fatty acid β -oxidation to promote the catabolism of macromolecules as bioenergetic substrates for ATP production. At the same time, AMPK suppresses the energetically costly synthesis of new macromolecules, in part by inhibiting mTORC1. The interplay between mTORC1 and AMPK is central to cellular metabolic homeostasis in fluctuating nutrient environments 14 . Intracellular nutrient sensors not only respond to metabolite levels, but also are commonly modulated by growth factor signalling pathways. For instance, mTORC1 is activated by concerted input from intracellular amino acids and the PI3K effector, the serine-threonine kinase Akt 11, 12 . Conversely, Akt antagonizes activation of AMPK 15 . These principles allow cells to integrate metabolic status and growth factor signals in order to regulate macromolecular synthesis and growth.
Transporter-based glucose and amino acid uptake
Glucose and amino acids are abundant in the extracellular fluids of mammalian organisms and constitute principal cellular nutrients. Owing to their hydrophilic nature, these low-molecular-mass nutrients cannot diffuse across the plasma membrane; instead, they are imported by cells through nutrient transporters of the solute carrier family. While quiescent cells express only basal levels of nutrient transporters and therefore are limited in their capacity to take up glucose and amino acids, cells increase their uptake when stimulated with growth factors 16 . Downstream of growth factors, PI3K and its effector Akt are central regulators of cellular glucose uptake (Fig. 4a) . Upon growth factor stimulation, activation of PI3K and Akt causes translocation of various glucose transporters, such as the insulin-regulated GLUT4 and the ubiquitously expressed GLUT1, to the cell surface [16] [17] [18] [19] [20] . In addition, Akt increases the activity of the enzyme hexokinase, which phosphorylates glucose, resulting in the intracellular capture of glucose. PI3K signalling also promotes glucose utilization by activating several glycolytic enzymes, including phosphofructokinase and aldolase, which collectively increase flux through glycolysis 19, [21] [22] [23] . Similarly, Ras GTPases stimulate glucose metabolism by increasing the expression of GLUT1, hexokinase and several glycolytic enzymes [24] [25] [26] . Mutations that constitutively activate PI3K or Ras signalling, which are among the most common genetic events in human cancer, share the ability to enhance cellular glucose uptake and glycolytic flux independently of growth factor stimulation. Glucose uptake is also promoted by oncogenic mutations in upstream receptor tyrosine kinases; for instance, epidermal growth factor receptor mutations increase surface presentation of the glucose transporter GLUT3 27 . These findings explain the century-old observation by German physiologist Otto Warburg that tumour cells display a marked increase in glucose consumption compared to their non-transformed counterparts 28 . High glucose uptake rates can be detected in many different cancer types by 18 F-deoxyglucose positron emission tomography (FDG-PET), which is now a commonly used diagnostic tool.
Although glucose uptake in mammalian cells is predominantly regulated by growth factors, it can be secondarily modulated by cellintrinsic sensors. AMPK increases GLUT1 concentration in the plasma membrane by inhibiting its thioredoxin-interacting protein (TXNIP)-mediated endocytosis 29 , and increases the rate of glucose transport by phosphorylating GLUT1 directly 30, 31 . Activation of AMPK by a decline in cellular energy levels therefore improves the availability of glucose as a bioenergetic substrate to restore energy balance. Cells can also increase glucose uptake when ATP production through the mitochondrial respiratory chain is limited by decreased oxygen availability or produces harmful levels of reactive oxygen species. When electron build-up in the respiratory chain results in high mitochondrial production of reactive oxygen species and accumulation of TCA cycle intermediates, activity of the transcription factor hypoxia-inducible factor 1 α (HIF1α ) increases, which in turn suppresses entry of glucose carbons into the TCA cycle and decreases oxidative phosphorylation 32, 33 . Concomitantly, HIF1α induces the expression of GLUT1 and lactate dehydrogenase, thereby increasing glucose uptake and glycolysis as an alternative means to generate ATP [34] [35] [36] . Owing to their biophysically diverse properties, amino acids require a variety of import systems with specificity for different amino acid classes. The regulation of amino acid transporters is still being elucidated, but growth factor signalling pathways clearly play an instructive role in this process. The transcription factor Myc, which is induced by growthpromoting signalling pathways and amplified in various tumours, induces expression of the glutamine transporters ASCT2 and SNAT5 (Fig. 4b) . Myc also upregulates glutaminase, the first enzyme of the glutaminolysis pathway, which funnels glutamine carbons into the TCA cycle 37, 38 . Expression or cell surface presentation of several other amino acid transporters, such as the neutral amino acid transporter LAT1, is induced by Myc or by PI3K-Akt signalling [38] [39] [40] . At the same time, Myc and PI3K-Akt stimulate ribosomal biogenesis and mTORC1-dependent translational initiation, respectively, thereby allocating the increased amino acid supply for protein synthesis.
Receptor-mediated endocytosis of nutrient carriers
A variety of nutrients are insoluble in the aqueous environment of living organisms and must be transported through extracellular fluids by protein carriers. Cells acquire such nutrients through plasma membrane receptors, which recognize nutrient carriers and initiate their internalization for subsequent cargo release in endolysosomal compartments 41 .
Receptor-mediated endocytosis is the main pathway through which cells obtain cholesterol and iron (Fig. 4c) . The low-density lipoprotein (LDL) receptor mediates uptake of LDL, which is the principal extracellular carrier of cholesterol and also contains phospholipids and triglycerides. Transferrin (Tfn) receptors mediate endocytosis of Tfn, the systemic carrier of iron. Through nutrient-sensing signalling pathways, cells monitor intracellular lipid and iron availability and adjust the expression of LDL and Tfn receptors accordingly. When cells become cholesteroldepleted, SREBP transcription factors induce expression of the LDL receptor to enhance cellular LDL uptake 9 . Upon iron deficiency, iron regulatory protein 1 stabilizes Tfn receptor mRNA and increases translation of the receptor protein to enhance transferrin endocytosis 42 . Although LDL and Tfn receptor levels are adjusted to intracellular nutrient availability under basal conditions, their absolute levels of expression and surface presentation are modulated by growth factors. Growth factor stimulation or expression of activated Akt leads to increased expression and surface presentation of the LDL receptor 40, 43 . PI3K-Akt signalling upregulates the LDL receptor at least in part by activating mTORC1, which potentiates SREBP-mediated gene expression 44 . Similarly, growth factors signal to PI3K and Akt to increase expression of Tfn receptors, although the underlying mechanism of this process remains unclear 40, [45] [46] [47] . Upregulation of the LDL receptor supports the survival and proliferation of glioblastoma cells, and elevated Tfn receptor levels have been documented in several cancer types 48, 49 . Together, these findings suggest that growth factor signalling pathways induce expression of LDL and Tfn receptors to increase nutrient supply for biomass formation, which could have nutritional benefits for transformed cells.
Macropinocytosis of proteins as an amino acid source
Although receptor-mediated endocytosis effects the uptake of specific macromolecules, metazoan cells also possess a non-selective endocytic pathway for bulk ingestion of extracellular solutes, which is referred to as macropinocytosis 50, 51 . Macropinocytosis is initiated by actindriven protrusions of the plasma membrane that engulf portions of the environment for internalization into large endocytic vesicles. These macropinosomes can subsequently be trafficked to the lysosome, where digestive enzymes degrade their macromolecular cargo and thereby create an intracellular nutrient source (Fig. 4d) . The conservation of macropinocytosis across eukaryotes suggests this endocytic pathway evolved together with the lysosomal system as a nutrient acquisition strategy in ancestral eukaryotic cells 50 . Indeed, unicellular amoeboid eukaryotes such as Dictyostelium can satisfy their dietary requirements through macropinocytosis of extracellular macromolecules. In mammalian cells, actin-driven membrane ruffling and subsequent macropinosome formation is an immediate response to growth factor stimulation 52, 53 . Downstream of growth-factoractivated receptor tyrosine kinases, the intracellular signalling cascade that triggers macropinocytosis is centred around Ras and PI3K, which induce membrane ruffles and macropinosome closure. Mammalian cells have little intrinsic macropinocytic activity without external stimulation. However, constitutively activated Ras GTPases induce macropinocytosis cell-autonomously in the absence of growth factors, and cancer cell lines harbouring Ras mutations commonly display high macropinocytic activity 54, 55 . Whereas glucose and amino acids are important nutrients for mammalian cells, macropinocytosis of extracellular proteins has emerged as another route for nutrient acquisition. By increasing macropinocytic activity, oncogenic Ras promotes the use of extracellular proteins as nutrients to decrease cellular dependence on an exogenous supply of free amino acids 56 . Ras-mutant cells can proliferate even in the complete absence of essential amino acids such as leucine by ingesting albumin, the most abundant protein in mammalian plasma 57, 58 . PI3K can also regulate macropinosome formation 50 . However, it remains to be investigated whether oncogenic activation of PI3K signalling shares the ability of oncogenic Ras to enhance the nutritional use of proteins. In vivo, tumours can siphon off a substantial fraction of circulating albumin 59 . Pancreatic cancers cells harbouring a KRAS mutation show increased uptake and intracellular catabolism of albumin compared to surrounding normal tissue, and this increase is blocked by inhibition of macropinocytosis 56, 60 . These findings suggest that extracellular proteins are an important nutritional source for cancer cells that reside in poorly perfused regions of tumours.
Endolysosomal recovery of diverse nutrients
Owing to its non-selective nature, macropinocytosis has the potential to provide nutrients other than amino acids. For instance, cells can use macropinocytosis to take up albumin, which functions as the main carrier of free fatty acids in mammalian plasma 61 . Internalized albumin can escape lysosomal degradation because it binds at the acidic pH of endosomes to the neonatal Fc receptor, which recycles albumin back to the cell surface 62 . This raises the possibility that cells can macropinocytose albumin, acquire its lipid cargo and release it back into the extracellular space or designate albumin for lysosomal degradation to access its amino acid content. Moreover, macropinocytosis can mediate the uptake of macromolecular structures such as membrane vesicles and apoptotic bodies 63 . These particles are abundant in damaged tissues and necrotic tumour regions and could supply a range of nutrients. Epithelial cells can also internalize whole neighbouring cells in a non-phagocytic form of engulfment referred to as entosis (Fig. 4e) . The internalized cell undergoes cell death and is catabolized by lysosomal hydrolases, releasing nutrients that sustain the survival and proliferation of starved cells 64 . Cell-in-cell structures that resemble entotic vacuoles have been found in several human cancers, raising the possibility that entosis can confer a metabolic advantage in nutrient-deprived tumours. The likelihood that a cell will engulf its neighbour is increased by oncogenic activation of KRAS 65 , suggesting that Ras signalling provides nutritional benefits by inducing the recovery of nutrients delivered to the lysosome by both macropinocytosis and entosis.
When cells do not have access to extracellular nutrients, they engage in the self-catabolic process of macroautophagy 66 . During autophagy, double-membrane vesicles called autophagosomes are formed, which engulf cytosolic constituents and organelles and subsequently fuse with lysosomes for cargo degradation by lysosomal enzymes (Fig. 4f) . Autophagy is frequently upregulated in cancer cells that reside in nutrient-deprived microenvironments 67 . Inhibition of autophagy consistently induces cell death and prevents growth of solid tumours 68, 69 . By recycling nutrients from intracellular macromolecules, autophagy represents an important cellular strategy to sustain viability during limited starvation periods. However, unlike macropinocytosis, autophagy is not induced by growth factor signalling and cannot support an increase in cell mass in the absence of extracellular nutrients; rather, it results in cellular atrophy 70 .
Coordination of nutrient acquisition routes
As described above, activation of PI3K and Ras by growth factors instructs cells both to import glucose and amino acids through nutrient transporters and to ingest macromolecules through the endolysosomal system. If growth factors provide a general signal to engage in nutrient uptake, how does a cell coordinate its different nutrient acquisition routes? There is evidence that mTORC1 helps to regulate a cell's preference for the use of either monomeric amino acids or proteins to support growth. Concerted signals from mTORC1 and its upstream activator Akt promote the expression and cell surface presentation of glucose and amino acid transporters 19, 20, 40 . At the same time, mTORC1 inhibits the autophagy initiator kinases Ulk1 and Ulk2 to prevent the catabolism of intracellular matter, and blocks catabolism of proteins that were internalized through macropinocytosis 57, 71, 72 . mTORC1 also limits lysosomal capacity by preventing the nuclear translocation of MiT/TFE transcription factors, which induce the expression of lysosomal biogenesis genes [73] [74] [75] . Thus, Akt-mTORC1 signalling defines a cellular state that is characterized by high rates of glucose and amino acid import through nutrient transporters and concomitant suppression of lysosomal catabolism of macromolecules (Fig. 3) . By suppressing macromolecular catabolism, mTORC1 helps cells to maximize biomass formation, but also renders them dependent on an extracellular supply of free amino acids. By contrast, when mTORC1 activity is reduced, cell surface levels of nutrient transporters decrease and enhanced lysosomal degradation of macropinocytosed proteins generates an intracellular amino acid source. Thereby, mTORC1 inhibition allows cells to sustain growth in nutrient-deprived environments such as poorly vascularized tumour regions 57 .
Flexible nutritional use of glucose and glutamine
Glucose and glutamine are key substrates for multiple metabolic pathways. Although mammals can in principal synthesize them de novo, cells often depend on exogenous glucose and glutamine supply. A feature of many cancer cells and other rapidly proliferating cells, such as those observed during development or an immune response, is the Warburg effect or aerobic glycolysis, which refers to the uncoupling of glycolysis from the TCA cycle despite abundant oxygen levels 28 . This metabolic state results from taking up large quantities of glucose and excreting the glucose carbons in excess of their biosynthetic and bioenergetic needs as lactate. Aerobic glycolysis increases the availability of glycolytic intermediates as precursors for various anabolic pathways when the ATP needs of a cell are saturated 2 . Glutamine is the second most-consumed nutrient of proliferating cells and is a major source of carbons to replenish TCA cycle intermediates 76, 77 . Despite the importance of glucose and glutamine, metabolic flexibility allows cells to compensate for deprivation of either glucose or glutamine by enhanced use of the other nutrient. Cells can funnel carbons from either glucose or glutamine into the TCA cycle to drive ATP production through mitochondrial respiration 78 . Glucose-derived acetyl coenzyme A (acetyl-CoA) functions as a precursor for fatty acid and cholesterol synthesis. However, when acetyl-CoA synthesis from glucose is reduced, reductive carboxylation of glutamine-derived α -ketoglutarate can step in to generate acetyl-CoA for lipogenesis 79, 80 . Some cancers also bypass the reliance on glucose or glutamine for acetyl-CoA production altogether by taking up exogenous acetate from which to synthesize acetyl-CoA 81, 82 .
In the absence of glucose, even some biosynthetic intermediates of glycolysis can be derived from glutamine carbons through the action of the TCA cycle and a mitochondrial form of the glycolytic enzyme phosphoenolpyruvate carboxykinase 83 . While glutaminolysis is the predominant way in which proliferating cells in culture replenish TCA cycle intermediates, analysis of in vivo tumour metabolism has demonstrated preferential use of glucose-derived pyruvate for TCA cycle anaplerosis through the action of pyruvate carboxylase [84] [85] [86] [87] . TCA cycle anaplerosis from other carbon sources can support de novo glutamine synthesis, which allows naive embryonic stem cells to proliferate in the complete absence of extracellular glutamine 88 . Beyond providing carbons for TCA cycle anaplerosis, glutamine is also a major source of reduced nitrogen for the synthesis of amino acids, nucleotides and hexosamines. However, various cancers express high levels of branched-chain amino acid transferases, which allow cells to use leucine, isoleucine and valine as nitrogen sources 89, 90 . Such metabolic adaptability provides a selective advantage for cancer cells that must survive or proliferate in the poorly perfused microenvironments of solid tumours, where the levels of glucose and glutamine fluctuate.
Uptake or biosynthesis of non-essential metabolites
Although cells must take up essential nutrients from the extracellular space, they can acquire non-essential metabolites from either exogenous sources or endogenous production. Most non-essential amino acids derive their carbon backbone from intermediates of glycolysis and the TCA cycle, and their nitrogen from either ammonia or transamination of any excess amino acid. Therefore, if glucose and glutamine are abundant, mammalian cells can synthesize other non-essential amino acids in sufficient quantities to engage in macromolecular synthesis and growth. Indeed, several TCA-cycle-derived amino acids are preferentially produced intracellularly, regardless of their presence in the environment 91 . Cells sense non-essential amino acid shortages through the general control nonderepressible 2 (GCN2)-activating transcription factor 4 (ATF4) pathway, which is activated by uncharged tRNAs and induces expression of various amino acid biosynthesis enzymes. Because ATF4-deficient cells fail to induce biosynthetic programmes for asparagine and serine, they become auxotrophic for these normally non-essential amino acids 92, 93 . Even when expressing asparagine synthetase, cells rely on exo genous asparagine to survive glutamine deprivation, because the amide nitrogen of asparagine is donated directly from glutamine 93, 94 . Under nutrient-rich conditions, proliferating cells produce significant quantities of fatty acids de novo. Increased expression of fatty acid synthase and enhanced lipogenesis have been observed in several cancer types 95 . However, the biosynthetic demands of lipogenesis are substantial, and lipid production in cultured cells is suppressed by exogenous addition of lipids or lipoproteins 96, 97 . Proliferating cells consistently take up extracellular lipids and use them as precursors for membrane lipids 91, 98 . Unsaturated fatty acids become essential nutrients under hypoxia, because oxygen limitation impairs the activity of stearoyl-CoA desaturase 1 (SCD), the enzyme that introduces a double bond into fatty acids before their incorporation into membrane phospholipids. As a consequence, deprivation of unsaturated fatty acids triggers apoptosis of lipogenic cancer cells subjected to hypoxia 99 . Oncogenic variants of KRAS and HRAS promote cellular uptake of lysophospholipids with an unsaturated fatty acid moiety, which support cell proliferation under hypoxia when SCD becomes inactive 100 . There is evidence that increased uptake of exo genous lipids is also selected for under some circumstances in vivo. For instance, overexpression of the scavenger receptor CD36, which mediates the cellular influx of lipids from circulating lipoproteins, increases the metastatic potential of tumour cells, whereas genetic or pharmacological inhibition of CD36 suppresses metastasis formation 101 . Because mammals lack the glyoxylate cycle, which is required for synthesis of glucose and amino acids from fatty acid carbons, the use of fatty acids in biosynthesis is limited to lipid production. However, fatty acid carbons are an efficient bioenergetic substrate and their oxidation generates twofold more ATP per mole than oxidation of glucose or amino acids. Fatty acid oxidation can provide sufficient ATP to rescue the viability of cells when glucose becomes limiting 102 . Even under nutrientreplete conditions, some cancer types use fatty acid oxidation to maintain oxidative phosphorylation 103, 104 .
Metabolic cooperation in tumour microenvironments
The organization of metazoan organisms into multiple cell types allows functional compartmentalization of cellular metabolism; most cell types use only a subset of an organism's metabolic pathways and rely on nutrient supply by other tissues. For instance, the liver synthesizes glucose, triglycerides and plasma proteins, whereas adipose tissue stores triglycerides for future release as free fatty acids. The importance of dedicated metabolic organs for interorgan nutrient exchange is well established, but recent findings have demonstrated remarkable metabolic cooperation between cancer and stromal cells in the tumour microenvironment (Fig. 5) . Ovarian cancer cells induce lipolysis in nearby adipocytes, causing them to release fatty acids, which the cancer cells then acquire through upregulation of the fatty acid binding protein FABP4 105 . Glioblastomaassociated astrocytes express high levels of glutamine synthetase and support cancer cell proliferation by releasing glutamine into the tumour microenvironment 106 . Chronic myeloid leukaemia cells express only low levels of the xCT transporter, which mediates import of cystine, the oxidized dimer in which cysteine predominantly exists extracellularly. However, bone marrow stromal cells take up cystine in excess, causing them to secrete cysteine, which is taken up by tumour cells 107 . Pancreatic stellate cells secrete alanine, which is imported by tumour cells and converted to pyruvate as a bioenergetic substrate for the TCA cycle. Alanine release depends on stellate cell autophagy, suggesting that it is derived, at least in part, from lysosomal protein catabolism 108 . Fibroblasts also provide proteins as nutrients directly in the form of extracellular matrix, which can be endocytosed and catabolized by adjacent epithelial cells 109 . Together, these studies reveal the unexpected ability of malignant cells to supplement their metabolism with nutrients provided by neighbouring cells with complementary metabolic activities, which contributes substantially to tumour cell survival and proliferative capacity. Moreover, non-transformed cells often undergo phenotypic changes in the tumour microenvironment, which raises the possibility that tumour cells secrete factors that modulate the metabolism of neighbouring cells to their advantage 7 . Metabolic crosstalk need not be restricted to cells within a tumour. Pancreatic cancer development is accompanied by increased plasma levels of branched-chain amino acids that originate from protein breakdown in other organs 110 . The growth of various tumours is associated with increased triglyceride breakdown in adipose tissue and elevated plasma levels of free fatty acids, and wasting of adipose lipid stores can be inhibited by blocking lipolytic enzymes 111 . It remains to be clarified whether the increase in circulating amino acids and fatty acids provides nutritional benefits for tumour cells. However, such metabolic interactions between a tumour and distant organs could contribute to the cancer-associated wasting syndrome, cachexia.
Concluding remarks and future outlook
The study of cancer cell metabolism has begun to unravel how growth factor signals, or more specifically the oncogenes and tumour suppressors that constitute these pathways, regulates cellular nutrient uptake and usage. For instance, although macropinocytosis was the first endocytic pathway to be discovered in the early 20th century 112 , only recently has research into the induction of macropinocytosis by oncogenic Ras revealed its function in amino acid acquisition by mammalian cells [56] [57] [58] . Beyond their importance for tumour biology, insights from cancer metabolism have contributed substantially to the understanding of cellular metabolism in physiological contexts. For example, it has become clear that activated T cells and proliferating cells in developing embryos have metabolic traits reminiscent of the Warburg effect. Similarly, metabolic adaptations of cancer cells that proliferate in vascularly compromised tumours have foreshadowed findings in immune cells that navigate nutrient deficiencies at sites of infection or in the tumour microenvironment.
Despite these advances, our understanding of the regulation of cellular nutrient acquisition by signal transduction remains incomplete. Most studies focus on individual nutrients or cellular uptake pathways, but we lack an integrative view of how cells coordinate acquisition of the diverse nutrients required for growth. Many insights into cellular metabolism stem from the analysis of a single cell type or cancer or have focused on specific oncogenes. Yet the few comparative studies available suggest that cell type or tissue identity can profoundly influence cellular metabolism. Concentrations and fluxes of nutrients differ in interstitial fluids compared to the circulation, but measuring extracellular nutrient concentrations within tissues remains a technical challenge and the nutrient levels surrounding cells are thus poorly defined. Last, the question of how a cell's preference for distinct nutrient acquisition strategies is regulated remains unanswered. For instance, proliferating mammalian cells tend to use glucose and free amino acids for biomass formation, despite being surrounded by protein-rich extracellular fluids. By contrast, proliferating embryonic cells of oviparous animals depend entirely on catabolism of extracellular macromolecules deposited in the egg white and yolk. Understanding the factors that determine such differences in nutrient usage will be important to predict the efficacy of cancer therapeutics that target cellular metabolism, and to shed further light on metabolic features of metazoan cells.
